18 studies found for:    " December 03, 2008":" January 02, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
2 Active, not recruiting Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
3 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
4 Completed Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Conditions: HIV;   Contraception;   HIV Infections
Interventions: Drug: Depo Provera;   Device: Copper T Intrauterine contraception device
5 Completed
Has Results
Lopinavir/Ritonavir (Kaletra) PK in Children
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
6 Completed Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old
Condition: HIV (Human Immunodeficiency Virus)-Infected Adults
Interventions: Biological: HIV Vaccine 732461;   Biological: Placebo vaccine
7 Unknown  Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
8 Completed Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Conditions: Pregnancy;   Malaria;   HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine;   Drug: Mefloquine (full dose);   Drug: Mefloquine (split dose);   Drug: placebo;   Drug: mefloquine
9 Unknown  Examination of B Cell Responses in Human Blood
Condition: HIV Infections
Intervention:
10 Completed Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Conditions: Nasal Colonization With Staphylococcus Aureus;   HIV Infections
Interventions: Drug: Mupirocin calcium ointment, 2%;   Drug: Placebo ointment
11 Completed Plasma Citrulline Concentration in Tropical Enteropathy
Conditions: Malabsorption Syndromes;   Granulomatous Enteritis;   Enteritis;   HIV Enteropathy;   Ileal Diseases
Intervention:
12 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
13 Completed Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV Infection
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Atazanavir
14 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
15 Enrolling by invitation Safety And Efficacy Of Rifabutin In HIV Patients
Conditions: Non-tuberculous Mycobacterial Diseases (Including MAC Disease);   Tuberculosis;   Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections
Intervention: Drug: rifabutin
16 Completed Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients
Conditions: HIV;   Tuberculosis;   Latent Tuberculosis Infection
Intervention: Other: QTF-TB Gold and T-SPOT TB
17 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:
18 Completed TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Conditions: Pharmacokinetics;   Bioavailability;   HIV-1
Intervention: Drug: TMC278

Indicates status has not been verified in more than two years